Marijke Wasielewski

发表

Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

Nazneen Rahman, Carel Meijers, Julian Peto, 2002, Nature Genetics.

Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility.

Nazneen Rahman, Carel Meijers, Sheila Seal, 2003, American journal of human genetics.

Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines

Hans Clevers, John W. M. Martens, Stephen P. Ethier, 2010, Breast Cancer Research and Treatment.